Medtronic (NYSE: MDT) CFO receives new stock, option and PSU grants

Rhea-AI Filing Summary

Medtronic EVP & Chief Financial Officer Thierry Pieton reported equity awards dated August 3, 2026, including 11,537 restricted ordinary shares, 28,842 performance share units tied to three-year performance goals, and 81,945 stock options with an $86.68 exercise price expiring in 2036.

Insider Trade Summary

Net Buyer: 11,537 shares

Net Buy 3 txns

Insider Pieton Thierry

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Share Units F3, F4, F5	28,842	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F6	81,945	$0.00	$0.00
Grant/Award	Ordinary Shares F1, F2	11,537	$0.00	$0.00

Holdings After Transaction: Performance Share Units — 28,842 shares (Direct); Stock Option (Right to Buy) — 81,945 shares (Direct); Ordinary Shares — 49,645 shares (Direct)

Footnotes (6)

1. F1. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
2. F2. Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. F3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
4. F4. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
5. F5. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
6. F6. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Key Figures

Restricted shares granted: 11,537 shares Shares owned after grant: 49,645 shares PSU target share amount: 28,842 shares +4 more

7 metrics

Restricted shares granted 11,537 shares Ordinary Shares granted as restricted stock units on 2026-08-03

Shares owned after grant 49,645 shares Direct Medtronic ordinary share holdings after 2026-08-03 transaction

PSU target share amount 28,842 shares Target shares issuable if PSU performance metrics are achieved

PSU maximum share amount 69,221 shares Maximum shares issuable if PSU performance metrics are fully achieved

Stock options granted 81,945 options Stock Option (Right to Buy) grant on 2026-08-03

Option exercise price $86.68 per share Exercise price for 81,945 stock options expiring 2036-08-03

Option expiration date 2036-08-03 Expiration date for stock options granted to the CFO

Key Terms

restricted stock units, performance share units, dividend reinvestment, Stock Option (Right to Buy)

4 terms

restricted stock units financial

"Represents restricted stock units that vest 100% on the third anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance share units financial

"Each performance share unit represents a contingent right to receive one share"

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

dividend reinvestment financial

"Includes 534 shares acquired through dividend reinvestment since the last report"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) reported as a derivative security grant"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 07:59 PM Accepted by SEC EDGAR 08/04/2026 - 07:59 PM Learn about SEC filing dates

FAQ

What equity awards did Medtronic (MDT) CFO Thierry Pieton report on this Form 4?

Thierry Pieton reported 11,537 restricted ordinary shares, 28,842 performance share units at target, and 81,945 stock options with an $86.68 exercise price, all granted as equity compensation on August 3, 2026.

How many Medtronic (MDT) shares does Thierry Pieton hold after these grants?

After the reported grants, Thierry Pieton directly holds 49,645 Medtronic ordinary shares. This total includes 534 shares acquired through dividend reinvestment since his prior ownership report.

What are the terms of Thierry Pieton’s new Medtronic (MDT) stock options?

Pieton received 81,945 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options vest at 25% per year starting on the first anniversary of the grant.

How many Medtronic (MDT) shares can Thierry Pieton receive from his new PSUs?

The new performance share units reference up to 69,221 shares. If target metrics are met, 28,842 shares are issued; at maximum performance, 69,221 shares are issued; if minimum thresholds are not met, zero shares may vest.

When will Thierry Pieton’s Medtronic (MDT) restricted stock units vest?

The restricted stock units represented by the 11,537 ordinary shares vest 100% on the third anniversary of the grant date, providing a time-based vesting schedule linked to continued service.

What performance period applies to Thierry Pieton’s new Medtronic (MDT) PSUs?

The performance share units use a three-year performance period. Certain performance conditions are scheduled to be assessed by April 27, 2029, determining how many shares, if any, will ultimately be issued.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pieton Thierry

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/03/2026		A		11,537(1)	A	$0	49,645(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units	(3)	08/03/2026		A		28,842		(4)	(4)	Ordinary Shares	28,842(5)	$0	28,842	D
Stock Option (Right to Buy)	$86.68	08/03/2026		A		81,945		(6)	08/03/2036	Ordinary Shares	81,945	$0	81,945	D

Explanation of Responses:

1. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

2. Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person.

3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

4. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

5. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

6. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)